Skip Navigation
Skip to contents

Headache and Pain Research : Headache and Pain Research

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Korean J Headache > Volume 6(1); 2005 > Article
편두통 급성기 치료의 실패: 원인과 대책
Jeong Wook Park
Korean Journal of Headache 2005;6(1):26-33

Published online: June 30, 2005
대한두통학회 학회지
prev next
  • 436 Views
  • 43 Download

Acute management of migraine attacks is often difficult and many patients show to be refractory to treatment. As therapeutic option multiply, it is increasingly important to understand patients's attitudes and preferences regarding various treatment characteristics. A survey of populaton based sample of mig- raineurs indicated that majority of patients consider complete relief of headache, no recurrence, and rapid onset of action as important attributes of acute migraine therapy. In this paper, we also summarize and categorize the common reasons for treatment failure in acute management. That is, the diagnosis is in- complete or incorrect; important exacerbating factors have been missed; pharmacotherapy has been inade- quate; other factors, including unrealistic expectations and comorbidity. Finally we describe the strategy for swithching the way to care when primary pharmacotherapy was inadequate and suggest drugs that could be used for case of refractory to triptans. Korean Journal of Headache 6(1):26-33, 2005

  • Cite this Article
    Cite this Article
    export Copy Download
    Close
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    편두통 급성기 치료의 실패: 원인과 대책
    Korean J Headache. 2005;6(1):26-33.   Published online June 30, 2005
    Close
Related articles

Headache and Pain Research : Headache and Pain Research
TOP